18F-FDG PET biomarker of individual cerebral metabolic connectivity in focal epilepsy subtypes and association with prognosis - Scorecard - MDSpire

18F-FDG PET biomarker of individual cerebral metabolic connectivity in focal epilepsy subtypes and association with prognosis

  • By

  • Li Li Liu

  • Zhen Peng Chen

  • Zhehao Lyu

  • Dongxue Wang

  • Bing Han

  • Ping Li

  • June 16, 2026

  • 0 min

Share

Clinical Scorecard: Assessment of 18F-FDG PET as a Biomarker for Cerebral Metabolic Connectivity Variations in Subtypes of Focal Epilepsy and Its Prognostic Implications

At a Glance

CategoryDetail
Condition
Key MechanismsAlterations in metabolic connectivity assessed by 18F-FDG PET SUV parameters
Target Population
Care Setting

Key Highlights

  • Distinct topological characteristics of metabolic networks in RTLE, LTLE, and ETLE
  • Significant alterations in metabolic network connectivity compared to healthy controls

Guideline-Based Recommendations

Diagnosis

  • Clinical diagnoses based on comprehensive evaluations according to ILAE criteria

Management

  • Regular antiepileptic drug (AED) treatment

Monitoring & Follow-up

  • Standardized assessment of prognosis using ILAE outcome classification

Risks

    Patient & Prescribing Data

    116 patients with focal epilepsy (45 LTLE, 44 RTLE, 27 ETLE)

    All patients received regular AED treatment

    Clinical Best Practices

    • Utilize 18F-FDG PET in conjunction with MRI for preoperative evaluations

    Related Resources & Content

    Original Source(s)

    Related Content